Clinical trial
A Phase II Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung
NCT03083041 is registered in ClinicalTrials.gov with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 13, 2017
- Completion date
- April 22, 2022
- Enrollment
- 210 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.